Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Activity Monitoring Assessment of Opiate Withdrawal - 4

This study has been completed.
Sponsor:
Collaborator:
Washington D.C. Veterans Affairs Medical Center
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00000335
First received: September 20, 1999
Last updated: January 30, 2017
Last verified: December 2002
  Purpose
The purpose of this study is to determine if hyperactivity accompanies abrupt opiate withdrawal in heroin addicts, to determine if computerized solid state activity monitors are capable of quantifying hyperactivity, and to quantify the physical and affective symptoms occurring during abrupt withdrawal in heroin addicts and morphine's capacity to alleviate these symptoms.

Condition Intervention Phase
Opioid-Related Disorders
Drug: Morphine
Phase 2

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Activity Monitoring Assessment of Opiate Withdrawal

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Depression
  • Anxiety
  • Withdrawal severity
  • Activity
  • Opiate secondary withdrawal

Estimated Enrollment: 0
Actual Study Start Date: September 30, 1995
Study Completion Date: May 20, 1996
Primary Completion Date: March 20, 1996 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   21 Years to 55 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria
Please contact site for information.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000335

Locations
United States, District of Columbia
Washington DC VA
Washington, District of Columbia, United States, 20422
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
Washington D.C. Veterans Affairs Medical Center
Investigators
Principal Investigator: Steven Deutsch, M.D. Washington D.C. Veterans Affairs Medical Center
  More Information

Publications:
1996 CPDD, NIDA Research Monograph

ClinicalTrials.gov Identifier: NCT00000335     History of Changes
Other Study ID Numbers: NIDA-3-0009-4
Y01-3-0009-4
Study First Received: September 20, 1999
Last Updated: January 30, 2017

Keywords provided by National Institute on Drug Abuse (NIDA):
opioid dependence

Additional relevant MeSH terms:
Opioid-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Morphine
Analgesics, Opioid
Narcotics
Central Nervous System Depressants
Physiological Effects of Drugs
Analgesics
Sensory System Agents
Peripheral Nervous System Agents

ClinicalTrials.gov processed this record on May 22, 2017